The newsroom

admin

RespondHealth | Microsoft Collaboration

RespondHealth, a real-world evidence (RWE) clinical discovery company, is pleased to announce a new integration with Microsoft to bring AI-powered solutions to the healthcare and life sciences (HLS) sectors.

Read More »
admin

IMPACC Symptom Tracker launched for NIH-NIAID – Boston Children’s Hospital Coronavirus Study

Bethesda, MD (August 17, 2021)—The immediate impacts of COVID-19 are increasingly documented and understood, however, the long-term consequences of infection and recovery are still unknown. To address these questions, My Own Med, Inc. (MyOwnMed) is playing an important role in support of the new NIH IMPACC (IMmunoPhenotyping Assessment in a COVID-19 Cohort) study. The IMPACC study will use the MyOwnMed ECOS Mobile app, a comprehensive digital remote monitoring tool, to capture direct-from-patient, real-world evidence and will access important data and custom analytics through the MyOwnMed ECOS Portal.

Read More »